Skip to main content
. 2019 Jul 29;19:668. doi: 10.1186/s12879-019-4181-2

Table 1.

Clinical characteristic of influenza associated hospitalizations during the 2017-2018 influenza and 2011-2017 seasons

Variables n (%) 2011-2017 (n = 169) 2017-2018 (n = 289) P value
Gender-male 102 (60.4) 169 (58.5) 0.693
Age groups
 <14 years 22 (13.0) 37 (12.8)
 14- years 81 (47.9) 129 (44.6) 0.751
 >=60 years 66 (39.1) 123 (42.6)
Co-morbidities
 Cardiovascular diseases 55 (32.5) 120 (41.5) 0.056
 Respiratory diseases 17 (5.9) 24 (8.3) 0.526
 Chronic renal diseases 11 (6.5) 22 (7.6) 0.659
 Chronic liver diseases 11 (6.5) 27 (9.3) 0.289
 Diabetes mellitus 18 (10.7) 29 (10.0) 0.834
 Cancer and hematological diseases 56 (33.1) 83 (28.7) 0.321
 Stroke and Neuromuscular diseases 15 (8.9) 17 (5.9) 0.225
 Immunosuppressant 19 (11.2) 38 (13.1) 0.551
Pregnancy 0 (0) 2 (0.7) 0.533
Postmortum within 30 days after delivery 0 (0) 1 (0.3) 1.000
Current smoking 20 (6.9) 57 (19.7)* 0.029
Received seasonal or influenza A (H1N1) vaccination 0 (0) 0 (0.0) NA
Symptoms and Lab findings
 Fever (temp >=38) 159 (94.1) 257 (88.9) 0.065
 Cough 141 (83.4) 247 (85.5) 0.559
 Dyspnea 17 (5.9) 50 (17.3)* 0.034
 Hemoptysis 5 (3.0) 14 (4.8) 0.329
 CNS symptom 2 (1.2) 11 (3.8) 0.180
 WBC<4 50 (29.6) 70 (24.2) 0.266
 L%<20% 97 (59.1) 162 (56.1) 0.192
 Platelet<100 36 (65.0) 46 (15.9) 0.286
 ALT >40 36 (21.4) 86 (30.9)* 0.029
 AST >40 54 (32.3) 109 (39.4) 0.137
 LDH >300 48 (35.6) 108 (42.7) 0.172
 CK>200 14 (10.4) 54 (21.3)** 0.007
 CRP>8 121 (79.1) 196 (75.1) 0.355
 ESR >20 67 (39.6) 98 (60.1) 0.420
Treatment on admission
 Antibiotics use 160 (94.7) 258 (89.3)* 0.048
21 (12.4) 33 (11.4) 0.747
 Oseltamivir 147 (87.0) 222 (76.8)** 0.008
 Traditional Chinese Medicine 28 (16.6) 64 (22.1) 0.151
 Glucocorticoids 64 (37.9) 134 (46.4) 0.077
Outcome
 Total In-hospital fatality 2 (1.2) 19 (6.6)** 0.008

*, **. Boldface values indicate (*P <.05; **P <.01). Comparison of the 2017-2018 influenza season with control group (influenza season 2011-2017). WBC, white cell (×109/L); L%, lymphocyte percent; PLT, platelet (×109/L); ALT alanine aminotransferase (U/L), AST aspartate aminotransferase (U/L), LDH lactate dehydrogenase (U/L), CK creatine kinase (U/L), CRP C-reactive protein (mg/L), ESR erythrocyte sedimentation rate (mm/h). IQR interquartile range, NA not available